Global Heart Failure POC and LOC Devices Market Size Study, By Type, By Technology, By End-use, and Regional Forecasts 2022-2032

Description

The Global Heart Failure POC and LOC Devices Market is valued at approximately USD 88.27 million in 2023 and is expected to grow at a CAGR of 15.09% over the forecast period 2024-2032. Driven by advancements in microfluidics and lab-on-a-chip (LOC) technologies, the market is revolutionizing diagnostics, particularly for heart failure. These devices facilitate rapid, cost-effective, and high-throughput testing, providing real-time insights into cardiac health. The rising prevalence of cardiovascular diseases (CVD) globally and an increasing demand for early detection and personalized treatment further support the market's growth trajectory.

The prevalence of diabetes and cardiovascular diseases has emerged as a major driver for the adoption of point-of-care (POC) diagnostics. For example, approximately 30% of diabetic patients develop heart failure, highlighting the urgent need for accessible and effective diagnostic tools. Innovations such as Roche Diagnostics' NT-proBNP test for early detection of heart failure in type 2 diabetes (T2D) patients are transforming preventive care. By enabling early intervention, these solutions improve clinical outcomes and reduce hospital admissions, particularly in resource-constrained settings.

Technological advancements, such as microfluidics-based LOC systems, allow precise handling of small biological samples for detecting key biomarkers like NT-proBNP, Troponin I, and Troponin T, which are critical for heart failure diagnosis. The integration of these technologies with artificial intelligence (AI) further enhances their accuracy and efficiency. For instance, algorithms like CoDe-ACS combine patient data and metrics to predict cardiac risks, accelerating the decision-making process.

Regionally, North America dominates the market due to its advanced healthcare infrastructure, strong R&D investments, and increasing adoption of POC diagnostics in clinical and homecare settings. The Asia Pacific region, however, is projected to grow at the fastest rate, driven by rising healthcare awareness, the prevalence of chronic diseases, and ongoing investments in medical infrastructure.

Despite the promising growth, challenges such as undefined reimbursement frameworks for multi-analyte devices and adoption barriers in emerging economies remain significant hurdles. Nevertheless, ongoing innovations and government initiatives, like the KardiaTool project in Europe, aim to address these issues and expand access to affordable diagnostic technologies.

Major Market Players Included in this Report Are:

1. Abbott
2. Danaher
3. Siemens Healthineers
4. F. Hoffmann-La Roche Ltd
5. Quidel Corporation
6. bioMerieux S.A
7. Trinity Biotech
8. Abaxis, Inc
9. Philips Healthcare
10. Ultromics
11. Bio-Rad Laboratories
12. NanoDx, Inc.
13. Randox Laboratories
14. Ortho Clinical Diagnostics
15. Specific Diagnostics

The Detailed Segments and Sub-segments of the Market Are Explained Below:

By Type:

Proteomic Testing
Metabolomic Testing
Genomic Testing

By Technology:

Microfluidics
Array-based Systems
Others

By End-use:

Clinics
Hospitals
Home
Assisted Living Healthcare Facilities
Laboratory

By Region:

North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East & Africa
Saudi Arabia
UAE
South Africa
Kuwait

Years Considered for the Study Are as Follows:

Historical Year - 2022
Base Year - 2023
Forecast Period - 2024 to 2032

Key Takeaways:

Market Estimates & Forecast for 10 Years (2022-2032).
Annualized Revenue and Regional Analysis for Each Market Segment.
Comprehensive Geographical Landscape Analysis with Country-level Details.
Competitive Landscape with Market Share Analysis and Key Player Profiles.
Detailed Business Strategies and Recommendations for Future Market Approach.
Demand-side and Supply-side Analysis of the Market.
Analysis of Technological Advancements and Emerging Trends.

Chapter 1. Global Heart Failure POC and LOC Devices Market Executive Summary

1.1. Global Heart Failure POC and LOC Devices Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
- 1.3.1. By Type
- 1.3.2. By Technology
- 1.3.3. By End-use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Heart Failure POC and LOC Devices Market Definition and Research Assumptions

2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
  - 2.3.3.1. Availability
  - 2.3.3.2. Infrastructure
  - 2.3.3.3. Regulatory Environment
  - 2.3.3.4. Market Competition
  - 2.3.3.5. Economic Viability (Consumer's Perspective)
- 2.3.4. Demand Side Analysis
  - 2.3.4.1. Regulatory Frameworks
  - 2.3.4.2. Technological Advancements
  - 2.3.4.3. Environmental Considerations
  - 2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Heart Failure POC and LOC Devices Market Dynamics

3.1. Market Drivers
- 3.1.1. Rising prevalence of cardiovascular diseases globally
- 3.1.2. Technological advancements in POC and LOC diagnostics
- 3.1.3. Growing adoption of decentralized healthcare solutions
3.2. Market Challenges
- 3.2.1. Lack of defined reimbursement frameworks for multi-analyte diagnostics
- 3.2.2. High cost of advanced diagnostic devices
3.3. Market Opportunities
- 3.3.1. Increased R&D investments in LOC-based technologies
- 3.3.2. Growing demand for personalized medicine and early diagnostics
- 3.3.3. Expansion of healthcare infrastructure in emerging economies

Chapter 4. Global Heart Failure POC and LOC Devices Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
- 4.2.1. Political
- 4.2.2. Economic
- 4.2.3. Social
- 4.2.4. Technological
- 4.2.5. Environmental
- 4.2.6. Legal
4.3. Top Investment Opportunity
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Heart Failure POC and LOC Devices Market Size & Forecast by Type (2022-2032)

5.1. Segment Dashboard
5.2. Global Heart Failure POC and LOC Devices Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 5.2.1. Proteomic Testing
- 5.2.2. Metabolomic Testing
- 5.2.3. Genomic Testing

Chapter 6. Global Heart Failure POC and LOC Devices Market Size & Forecast by Technology (2022-2032)

6.1. Segment Dashboard
6.2. Global Heart Failure POC and LOC Devices Market: Technology Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 6.2.1. Microfluidics
- 6.2.2. Array-based Systems
- 6.2.3. Others

Chapter 7. Global Heart Failure POC and LOC Devices Market Size & Forecast by End-use (2022-2032)

7.1. Segment Dashboard
7.2. Global Heart Failure POC and LOC Devices Market: End-use Revenue Trend Analysis, 2022 & 2032 (USD Million)
- 7.2.1. Clinics
- 7.2.2. Hospitals
- 7.2.3. Home
- 7.2.4. Assisted Living Healthcare Facilities
- 7.2.5. Laboratory

Chapter 8. Global Heart Failure POC and LOC Devices Market Size & Forecast by Region (2022-2032)

8.1. North America Heart Failure POC and LOC Devices Market
- 8.1.1. U.S. Heart Failure POC and LOC Devices Market
- 8.1.2. Canada Heart Failure POC and LOC Devices Market
- 8.1.3. Mexico Heart Failure POC and LOC Devices Market
8.2. Europe Heart Failure POC and LOC Devices Market
- 8.2.1. UK Heart Failure POC and LOC Devices Market
- 8.2.2. Germany Heart Failure POC and LOC Devices Market
- 8.2.3. France Heart Failure POC and LOC Devices Market
- 8.2.4. Italy Heart Failure POC and LOC Devices Market
- 8.2.5. Spain Heart Failure POC and LOC Devices Market
- 8.2.6. Denmark Heart Failure POC and LOC Devices Market
- 8.2.7. Sweden Heart Failure POC and LOC Devices Market
- 8.2.8. Norway Heart Failure POC and LOC Devices Market
8.3. Asia Pacific Heart Failure POC and LOC Devices Market
- 8.3.1. Japan Heart Failure POC and LOC Devices Market
- 8.3.2. China Heart Failure POC and LOC Devices Market
- 8.3.3. India Heart Failure POC and LOC Devices Market
- 8.3.4. Australia Heart Failure POC and LOC Devices Market
- 8.3.5. Thailand Heart Failure POC and LOC Devices Market
- 8.3.6. South Korea Heart Failure POC and LOC Devices Market
8.4. Latin America Heart Failure POC and LOC Devices Market
- 8.4.1. Brazil Heart Failure POC and LOC Devices Market
- 8.4.2. Argentina Heart Failure POC and LOC Devices Market
8.5. Middle East & Africa Heart Failure POC and LOC Devices Market
- 8.5.1. Saudi Arabia Heart Failure POC and LOC Devices Market
- 8.5.2. UAE Heart Failure POC and LOC Devices Market
- 8.5.3. South Africa Heart Failure POC and LOC Devices Market
- 8.5.4. Kuwait Heart Failure POC and LOC Devices Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Abbott
- 9.1.2. Danaher
- 9.1.3. Siemens Healthineers
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. F. Hoffmann-La Roche Ltd.
- 9.3.2. Quidel Corporation
- 9.3.3. bioMerieux S.A
- 9.3.4. Trinity Biotech
- 9.3.5. Abaxis, Inc.
- 9.3.6. Philips Healthcare
- 9.3.7. Bio-Rad Laboratories
- 9.3.8. NanoDx, Inc.
- 9.3.9. Ortho Clinical Diagnostics
- 9.3.10. Specific Diagnostics

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes